Durante et al. have indicated that the tumor-infiltrating CD8+ T cells in uveal melanoma mainly express the lymphocyte activation gene 3 (LAG3) rather than CTLA-4 and PD-1; this might explain the low response rates of affected patients to the current method of immune checkpoint inhibitors administration [171,172]. This evidence concerns the gene LAG3 and uveal melanoma.